IRS2 and breast cancer: Mammary tumor metastasis is significantly diminished in PyV-MT:Irs-2-/- mice, and Irs-1 deficient tumors that express elevated levels of active (i.e. tyrosine phosphorylated) Irs-2 have enhanced metastatic rates [75,79].